<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33338825</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>02</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>02</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1872-6968</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>200</Volume>
            <PubDate>
              <Year>2021</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical neurology and neurosurgery</Title>
          <ISOAbbreviation>Clin Neurol Neurosurg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Guillain-Barre Syndrome and COVID-19: A case report.</ArticleTitle>
        <Pagination>
          <StartPage>106413</StartPage>
          <MedlinePgn>106413</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clineuro.2020.106413</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0303-8467(20)30756-3</ELocationID>
        <Abstract>
          <AbstractText>• Reports of Guillain-Barre Syndrome in the setting of a COVID-19 viral infection are increasing. • Dysautonomia in Guillain-Barre Syndrome and COVID-19. • Guillain-Barre Syndrome and COVID-19 in the critically-ill patient.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bueso</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA. Electronic address: tulio.bueso@ttuhsc.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Montalvan</LastName>
            <ForeName>V</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gomez</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ball</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shoustari</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Pulmonology and Critical Care, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Julayanont</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jumper</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Pulmonology and Critical Care, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Clin Neurol Neurosurg</MedlineTA>
        <NlmUniqueID>7502039</NlmUniqueID>
        <ISSNLinking>0303-8467</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020275" MajorTopicYN="N">Guillain-Barre Syndrome</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009460" MajorTopicYN="N">Neurologic Examination</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054969" MajorTopicYN="N">Primary Dysautonomias</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">COVID-19</Keyword>
        <Keyword MajorTopicYN="Y">Guillain-Barré syndrome</Keyword>
        <Keyword MajorTopicYN="Y">IVIG</Keyword>
        <Keyword MajorTopicYN="Y">Polyneuropathies</Keyword>
        <Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>20</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33338825</ArticleId>
        <ArticleId IdType="pmc">PMC7718853</ArticleId>
        <ArticleId IdType="doi">10.1016/j.clineuro.2020.106413</ArticleId>
        <ArticleId IdType="pii">S0303-8467(20)30756-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Montalvan V., Lee J., Bueso T., De Toledo J., Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin. Neurol. Neurosurg. 2020;194 doi: 10.1016/j.clineuro.2020.105921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clineuro.2020.105921</ArticleId>
            <ArticleId IdType="pmc">PMC7227498</ArticleId>
            <ArticleId IdType="pubmed">32422545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leonhard S.E. Diagnosis and management of Guillain-Barre syndrome in ten steps. Nat. Rev. Neurol. 2019;15(11):671–683.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6821638</ArticleId>
            <ArticleId IdType="pubmed">31541214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pfeiffer G. Dysautonomie bei Guillain-Barré-Syndrom [Dysautonomia in Guillain-Barré syndrome] Nervenarzt. 1999;70(2):136–148. doi: 10.1007/s001150050414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s001150050414</ArticleId>
            <ArticleId IdType="pubmed">10098149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawn N.D. Anticipating mechanical ventilation in Guillain-Barre syndrome. Arch. Neurol. 2001;58(6):893–898.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11405803</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
